Cargando…
Predictors of vision‐related quality of life in patients with macular oedema receiving intra‐vitreal anti‐VEGF treatment
PURPOSE: To determine which demographic and clinical characteristics are predictive of vision‐related quality of life (VrQoL) and quality of life (QoL) in patients with macular oedema receiving intravitreal anti‐vascular endothelial growth factor (VEGF) treatment. METHODS: Vision‐related quality of...
Autores principales: | Rausch‐Koster, Petra T., Rennert, Katharina N., Heymans, Martijn W., Verbraak, Frank D., van Rens, Ger H. M. B., van Nispen, Ruth M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324141/ https://www.ncbi.nlm.nih.gov/pubmed/35366334 http://dx.doi.org/10.1111/opo.12984 |
Ejemplares similares
-
Calibration of the Dutch EyeQ to Measure Vision Related Quality of Life in Patients With Exudative Retinal Diseases
por: Rausch-Koster, T. Petra, et al.
Publicado: (2022) -
Optimizing Computer Adaptive Test Performance: A Hybrid Simulation Study to Customize the Administration Rules of the CAT-EyeQ in Macular Edema Patients
por: Rausch-Koster, T. Petra, et al.
Publicado: (2022) -
Anxiety and depression in patients who receive anti‐VEGF treatment and the usability and feasibility of e‐mental health support: the E‐PsEYE pilot study
por: van der Aa, Hilde PA, et al.
Publicado: (2021) -
Translation and content validity of the Dutch Impact of Vision Impairment questionnaire assessed by Three-Step Test-Interviewing
por: Rausch – Koster, T. P., et al.
Publicado: (2021) -
Economic evaluation of an e-mental health intervention for patients with retinal exudative diseases who receive intraocular anti-VEGF injections (E-PsEYE): protocol for a randomised controlled trial
por: van der Aa, Hilde P A, et al.
Publicado: (2017)